Showing results (31-40 of 39) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Allergy|April 9, 2022
Platelet-activating factor acetylhydrolase is a biomarker of severe anaphylaxis in childrenJulia E M Upton, Jennifer A Hoang, Matilde Leon-Ponte, et al.The New England Journal of Medicine|January 4, 2008
Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxisPeter Vadas, Milton Gold, Boris Perelman, et al.Ecological Applications : a Publication of the Ecological Society of America|December 29, 2017
Underestimation of N2 O emissions in a comparison of the DayCent, DNDC, and EPIC modelsRichard K Gaillard, Curtis D Jones, Pete Ingraham, et al.The World Allergy Organization Journal|March 23, 2026
Anaphylaxis events in the PIONEER study of avapritinib in indolent systemic mastocytosisThanai Pongdee, Mariana Castells, Cem Akin, et al.Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|February 24, 2015
Insights and advances in chronic urticaria: a Canadian perspectiveGordon Sussman, Jacques Hébert, Wayne Gulliver, et al.International Archives of Allergy and Immunology|May 23, 2019
Clinical Manifestations, Immunological Characteristics and Genetic Analysis of Patients with Hyper-Immunoglobulin M Syndrome in IranMitra Tafakori Delbari, Taher Cheraghi, Reza Yazdani, et al.American Journal of Medical Genetics. Part A|December 17, 2019
Utilization of the 2017 diagnostic criteria for hEDS by the Toronto GoodHope Ehlers-Danlos syndrome clinic: A retrospective reviewLaura McGillis, Nimish Mittal, Daniel Santa Mina, et al.The Journal of Allergy and Clinical Immunology|April 15, 2026
Avapritinib achieves long-term disease control with favorable safety in patients with indolent systemic mastocytosis over 3 yearsCem Akin, Vito Sabato, Jason Gotlib, et al.NEJM Evidence|February 6, 2024
Avapritinib versus Placebo in Indolent Systemic MastocytosisJason Gotlib, Mariana Castells, Hanneke Oude Elberink, et al.Pageof 4